PLX-Immune

N/A

Report date: 2025/03/20 14:43:14

Base Information

Drug NamePLX-Immune
Drug Alias NamePLX stem cell therapy induced with TNF-alpha and IFN-gamma (Pluristem)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionAngiogenesis inhibitorsCell cycle inhibitorsImmunostimulants +[4] 
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPluri Inc
China Registration ClassN/A

Develop Information

Active CompaniesPluri Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A